Skip to main content
Top

Current Rheumatology Reports

Issue 2/2016

Content (6 Articles)

Open Access Scleroderma (J Varga, Section Editor)

Cellular Therapies in Systemic Sclerosis: Recent Progress

Femke C. C. van Rhijn-Brouwer, Hendrik Gremmels, Joost O. Fledderus, Timothy R. D. Radstake, Marianne C. Verhaar, Jacob M. van Laar

Scleroderma (J Varga, Section Editor)

Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Vincent Sobanski, David Launay, Eric Hachulla, Marc Humbert

Antiphospholipid Syndrome (S Zuily, Section Editor)

Organ Damage and Quality of Life in Antiphospholipid Syndrome

P. Alba, J. A. Gómez-Puerta, M. V. Goycochea-Robles, M. C. Amigo

Antiphospholipid Syndrome (S Zuily, Section Editor)

Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome

Cécile M. Yelnik, Elizabeth Kozora, Simone Appenzeller

Pediatric Rheumatology (S Ozen, Section Editor)

Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases

Erkan Demirkaya, Alessandro Consolaro, Hafize Emine Sonmez, Gabriella Giancane, Dogan Simsek, Angelo Ravelli

Spondyloarthritis (MA Khan, Section Editor)

Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research

Henning Zeidler, Alan P. Hudson

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine